Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure

Extracorporeal membrane oxygenation (ECMO) is being used more often as a bridge to transplantation (BTT) in patients with acutely decompensated end-stage lung disease in Korea. ECMO as a BTT may be the only rescue strategy for severe acute respiratory failure, but many centers still consider it to b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2017-07, Vol.49 (6), p.1430-1435
Hauptverfasser: Yeo, H.J., Lee, S., Yoon, S.H., Lee, S.E., Cho, W.H., Jeon, D., Kim, Y.S., Kim, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1435
container_issue 6
container_start_page 1430
container_title Transplantation proceedings
container_volume 49
creator Yeo, H.J.
Lee, S.
Yoon, S.H.
Lee, S.E.
Cho, W.H.
Jeon, D.
Kim, Y.S.
Kim, D.
description Extracorporeal membrane oxygenation (ECMO) is being used more often as a bridge to transplantation (BTT) in patients with acutely decompensated end-stage lung disease in Korea. ECMO as a BTT may be the only rescue strategy for severe acute respiratory failure, but many centers still consider it to be a relative contraindication to lung transplantation because of its poor outcome. Because there are not enough lung donors, it is important to determine their optimal use. We reviewed and analyzed our experiences with the use of ECMO as a BTT in patients with acute respiratory failure. This was a retrospective analysis of all patients with acutely decompensated end-stage lung disease treated with ECMO as a bridge to lung transplantation between March 2012 and February 2016. Of the 194 patients who underwent respiratory ECMO over a 4-year period, a BTT strategy was used for 19 patients (median age, 58 years) on our institution's lung transplantation waiting list (15 veno-venous, 3 veno-veno-arterial, 1 veno-arterial). Fourteen patients (73.7%) were successfully bridged to transplantation; however, 3 died while on the waiting list and 2 returned to their baseline functions without transplantation. The overall in-hospital survival rate was 57.9% (11 of 19), including the 9 (64.3%) patients who underwent transplantation. Our findings support the view that well-selected candidates with acutely decompensated end-stage lung disease may be safely bridged until a suitable donor is identified. ECMO is not able to reverse the course of patients; however, it could be a life-saving option for patients with acute respiratory failure requiring lung transplantation. •ECMO is an important strategy in bridging patients with acute respiratory failure to transplantation.•Well-selected candidates with acute respiratory failure can be safely bridged until a suitable donor is identified.•ECMO could be a promising alternative bridging strategy to transplantation, allowing more physiological respiratory assistance.
doi_str_mv 10.1016/j.transproceed.2017.02.064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1923106271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134517303494</els_id><sourcerecordid>1923106271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-a76992ec2bc90697c583346550cf3ffe2aeaefc4a71f32b3dee9db1685a60ef43</originalsourceid><addsrcrecordid>eNqNkMtOxCAUhonR6Hh5BUNcuWnl0tLWnY7XZBKNl7gkDD0ok06pQI2-veho4tIVnPCd8x8-hA4oySmh4miRR6_6MHinAdqcEVrlhOVEFGtoQuuKZ0wwvo4mhBQ0o7wot9B2CAuSalbwTbTFEiQIrSdocf6ehmnnB-dBdXhmDeD7cUhlxCpghU-9bZ8BR4dnY_-MH76jO9VHFa3rse3xbbpBHwN-svEFn-gxAr6DMFivovMf-ELZbvSwizaM6gLs_Zw76PHi_GF6lc1uLq-nJ7NM85rETFWiaRhoNtcNEU2ly5rzQpQl0YYbA0yBAqMLVVHD2Zy3AE07p6IulSBgCr6DDldzk6DXEUKUSxs0dGlncGOQtGGcEsEqmtDjFaq9C8GDkYO3S-U_JCXyy7VcyL-u5ZdrSZhMrlPz_k_OOF-mt9_WX7kJOFsBkH77ZsHLoJMoDa31oKNsnf1PzidGQJkc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1923106271</pqid></control><display><type>article</type><title>Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Yeo, H.J. ; Lee, S. ; Yoon, S.H. ; Lee, S.E. ; Cho, W.H. ; Jeon, D. ; Kim, Y.S. ; Kim, D.</creator><creatorcontrib>Yeo, H.J. ; Lee, S. ; Yoon, S.H. ; Lee, S.E. ; Cho, W.H. ; Jeon, D. ; Kim, Y.S. ; Kim, D.</creatorcontrib><description>Extracorporeal membrane oxygenation (ECMO) is being used more often as a bridge to transplantation (BTT) in patients with acutely decompensated end-stage lung disease in Korea. ECMO as a BTT may be the only rescue strategy for severe acute respiratory failure, but many centers still consider it to be a relative contraindication to lung transplantation because of its poor outcome. Because there are not enough lung donors, it is important to determine their optimal use. We reviewed and analyzed our experiences with the use of ECMO as a BTT in patients with acute respiratory failure. This was a retrospective analysis of all patients with acutely decompensated end-stage lung disease treated with ECMO as a bridge to lung transplantation between March 2012 and February 2016. Of the 194 patients who underwent respiratory ECMO over a 4-year period, a BTT strategy was used for 19 patients (median age, 58 years) on our institution's lung transplantation waiting list (15 veno-venous, 3 veno-veno-arterial, 1 veno-arterial). Fourteen patients (73.7%) were successfully bridged to transplantation; however, 3 died while on the waiting list and 2 returned to their baseline functions without transplantation. The overall in-hospital survival rate was 57.9% (11 of 19), including the 9 (64.3%) patients who underwent transplantation. Our findings support the view that well-selected candidates with acutely decompensated end-stage lung disease may be safely bridged until a suitable donor is identified. ECMO is not able to reverse the course of patients; however, it could be a life-saving option for patients with acute respiratory failure requiring lung transplantation. •ECMO is an important strategy in bridging patients with acute respiratory failure to transplantation.•Well-selected candidates with acute respiratory failure can be safely bridged until a suitable donor is identified.•ECMO could be a promising alternative bridging strategy to transplantation, allowing more physiological respiratory assistance.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2017.02.064</identifier><identifier>PMID: 28736018</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Extracorporeal Membrane Oxygenation - methods ; Extracorporeal Membrane Oxygenation - mortality ; Female ; Hospital Mortality ; Humans ; Lung Transplantation ; Male ; Middle Aged ; Republic of Korea ; Respiratory Distress Syndrome, Adult - mortality ; Respiratory Distress Syndrome, Adult - therapy ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Waiting Lists - mortality</subject><ispartof>Transplantation proceedings, 2017-07, Vol.49 (6), p.1430-1435</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-a76992ec2bc90697c583346550cf3ffe2aeaefc4a71f32b3dee9db1685a60ef43</citedby><cites>FETCH-LOGICAL-c380t-a76992ec2bc90697c583346550cf3ffe2aeaefc4a71f32b3dee9db1685a60ef43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.transproceed.2017.02.064$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28736018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeo, H.J.</creatorcontrib><creatorcontrib>Lee, S.</creatorcontrib><creatorcontrib>Yoon, S.H.</creatorcontrib><creatorcontrib>Lee, S.E.</creatorcontrib><creatorcontrib>Cho, W.H.</creatorcontrib><creatorcontrib>Jeon, D.</creatorcontrib><creatorcontrib>Kim, Y.S.</creatorcontrib><creatorcontrib>Kim, D.</creatorcontrib><title>Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Extracorporeal membrane oxygenation (ECMO) is being used more often as a bridge to transplantation (BTT) in patients with acutely decompensated end-stage lung disease in Korea. ECMO as a BTT may be the only rescue strategy for severe acute respiratory failure, but many centers still consider it to be a relative contraindication to lung transplantation because of its poor outcome. Because there are not enough lung donors, it is important to determine their optimal use. We reviewed and analyzed our experiences with the use of ECMO as a BTT in patients with acute respiratory failure. This was a retrospective analysis of all patients with acutely decompensated end-stage lung disease treated with ECMO as a bridge to lung transplantation between March 2012 and February 2016. Of the 194 patients who underwent respiratory ECMO over a 4-year period, a BTT strategy was used for 19 patients (median age, 58 years) on our institution's lung transplantation waiting list (15 veno-venous, 3 veno-veno-arterial, 1 veno-arterial). Fourteen patients (73.7%) were successfully bridged to transplantation; however, 3 died while on the waiting list and 2 returned to their baseline functions without transplantation. The overall in-hospital survival rate was 57.9% (11 of 19), including the 9 (64.3%) patients who underwent transplantation. Our findings support the view that well-selected candidates with acutely decompensated end-stage lung disease may be safely bridged until a suitable donor is identified. ECMO is not able to reverse the course of patients; however, it could be a life-saving option for patients with acute respiratory failure requiring lung transplantation. •ECMO is an important strategy in bridging patients with acute respiratory failure to transplantation.•Well-selected candidates with acute respiratory failure can be safely bridged until a suitable donor is identified.•ECMO could be a promising alternative bridging strategy to transplantation, allowing more physiological respiratory assistance.</description><subject>Adult</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Extracorporeal Membrane Oxygenation - mortality</subject><subject>Female</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Lung Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Republic of Korea</subject><subject>Respiratory Distress Syndrome, Adult - mortality</subject><subject>Respiratory Distress Syndrome, Adult - therapy</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Waiting Lists - mortality</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtOxCAUhonR6Hh5BUNcuWnl0tLWnY7XZBKNl7gkDD0ok06pQI2-veho4tIVnPCd8x8-hA4oySmh4miRR6_6MHinAdqcEVrlhOVEFGtoQuuKZ0wwvo4mhBQ0o7wot9B2CAuSalbwTbTFEiQIrSdocf6ehmnnB-dBdXhmDeD7cUhlxCpghU-9bZ8BR4dnY_-MH76jO9VHFa3rse3xbbpBHwN-svEFn-gxAr6DMFivovMf-ELZbvSwizaM6gLs_Zw76PHi_GF6lc1uLq-nJ7NM85rETFWiaRhoNtcNEU2ly5rzQpQl0YYbA0yBAqMLVVHD2Zy3AE07p6IulSBgCr6DDldzk6DXEUKUSxs0dGlncGOQtGGcEsEqmtDjFaq9C8GDkYO3S-U_JCXyy7VcyL-u5ZdrSZhMrlPz_k_OOF-mt9_WX7kJOFsBkH77ZsHLoJMoDa31oKNsnf1PzidGQJkc</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Yeo, H.J.</creator><creator>Lee, S.</creator><creator>Yoon, S.H.</creator><creator>Lee, S.E.</creator><creator>Cho, W.H.</creator><creator>Jeon, D.</creator><creator>Kim, Y.S.</creator><creator>Kim, D.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure</title><author>Yeo, H.J. ; Lee, S. ; Yoon, S.H. ; Lee, S.E. ; Cho, W.H. ; Jeon, D. ; Kim, Y.S. ; Kim, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-a76992ec2bc90697c583346550cf3ffe2aeaefc4a71f32b3dee9db1685a60ef43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Extracorporeal Membrane Oxygenation - mortality</topic><topic>Female</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Lung Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Republic of Korea</topic><topic>Respiratory Distress Syndrome, Adult - mortality</topic><topic>Respiratory Distress Syndrome, Adult - therapy</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Waiting Lists - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeo, H.J.</creatorcontrib><creatorcontrib>Lee, S.</creatorcontrib><creatorcontrib>Yoon, S.H.</creatorcontrib><creatorcontrib>Lee, S.E.</creatorcontrib><creatorcontrib>Cho, W.H.</creatorcontrib><creatorcontrib>Jeon, D.</creatorcontrib><creatorcontrib>Kim, Y.S.</creatorcontrib><creatorcontrib>Kim, D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeo, H.J.</au><au>Lee, S.</au><au>Yoon, S.H.</au><au>Lee, S.E.</au><au>Cho, W.H.</au><au>Jeon, D.</au><au>Kim, Y.S.</au><au>Kim, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2017-07</date><risdate>2017</risdate><volume>49</volume><issue>6</issue><spage>1430</spage><epage>1435</epage><pages>1430-1435</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>Extracorporeal membrane oxygenation (ECMO) is being used more often as a bridge to transplantation (BTT) in patients with acutely decompensated end-stage lung disease in Korea. ECMO as a BTT may be the only rescue strategy for severe acute respiratory failure, but many centers still consider it to be a relative contraindication to lung transplantation because of its poor outcome. Because there are not enough lung donors, it is important to determine their optimal use. We reviewed and analyzed our experiences with the use of ECMO as a BTT in patients with acute respiratory failure. This was a retrospective analysis of all patients with acutely decompensated end-stage lung disease treated with ECMO as a bridge to lung transplantation between March 2012 and February 2016. Of the 194 patients who underwent respiratory ECMO over a 4-year period, a BTT strategy was used for 19 patients (median age, 58 years) on our institution's lung transplantation waiting list (15 veno-venous, 3 veno-veno-arterial, 1 veno-arterial). Fourteen patients (73.7%) were successfully bridged to transplantation; however, 3 died while on the waiting list and 2 returned to their baseline functions without transplantation. The overall in-hospital survival rate was 57.9% (11 of 19), including the 9 (64.3%) patients who underwent transplantation. Our findings support the view that well-selected candidates with acutely decompensated end-stage lung disease may be safely bridged until a suitable donor is identified. ECMO is not able to reverse the course of patients; however, it could be a life-saving option for patients with acute respiratory failure requiring lung transplantation. •ECMO is an important strategy in bridging patients with acute respiratory failure to transplantation.•Well-selected candidates with acute respiratory failure can be safely bridged until a suitable donor is identified.•ECMO could be a promising alternative bridging strategy to transplantation, allowing more physiological respiratory assistance.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28736018</pmid><doi>10.1016/j.transproceed.2017.02.064</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2017-07, Vol.49 (6), p.1430-1435
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_1923106271
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Extracorporeal Membrane Oxygenation - methods
Extracorporeal Membrane Oxygenation - mortality
Female
Hospital Mortality
Humans
Lung Transplantation
Male
Middle Aged
Republic of Korea
Respiratory Distress Syndrome, Adult - mortality
Respiratory Distress Syndrome, Adult - therapy
Retrospective Studies
Survival Rate
Treatment Outcome
Waiting Lists - mortality
title Extracorporeal Life Support as a Bridge to Lung Transplantation in Patients With Acute Respiratory Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T17%3A24%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracorporeal%20Life%20Support%20as%20a%20Bridge%20to%20Lung%20Transplantation%20in%20Patients%20With%20Acute%20Respiratory%20Failure&rft.jtitle=Transplantation%20proceedings&rft.au=Yeo,%20H.J.&rft.date=2017-07&rft.volume=49&rft.issue=6&rft.spage=1430&rft.epage=1435&rft.pages=1430-1435&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2017.02.064&rft_dat=%3Cproquest_cross%3E1923106271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1923106271&rft_id=info:pmid/28736018&rft_els_id=S0041134517303494&rfr_iscdi=true